Savara Inc Weighted Average Number of Shares Outstanding, Basic and Diluted
Savara Inc (SVRA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 152.77 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-11
- Savara Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 152.77M shares, a 98.42% increase year-over-year.
- Savara Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 152.81M shares, a 151.70% increase year-over-year.
- Savara Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 152.59M shares, a 153.09% increase year-over-year.
- Savara Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 152.46M shares, a 159.03% increase year-over-year.
- Savara Inc weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 133.92M shares, a 125.80% increase from fiscal 2020.
- Savara Inc weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 59.31M shares, a 48.17% increase from fiscal 2019.
- Savara Inc weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 40.03M shares, a 20.20% increase from fiscal 2018.
- Savara Inc weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 33.30M shares, a 90.06% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | 152.77M shares 10-Q · filed 2022-05-11 | 152.79M shares derived: average of 2 quarters · filed 2022-05-11 | 152.72M shares derived: average of 3 quarters · filed 2022-05-11 | 152.66M shares derived: average of 4 quarters · filed 2022-05-11 | ||||
| 2021-12-31 | 152.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 152.70M shares derived: average of 2 quarters · filed 2022-03-30 | 152.62M shares derived: average of 3 quarters · filed 2022-03-30 | 133.92M shares 10-K · filed 2022-03-30 | ||||
| 2021-09-30 | 152.59M shares 10-Q · filed 2021-11-12 | 152.52M shares derived: average of 2 quarters · filed 2021-11-12 | 127.62M shares 10-Q · filed 2021-11-12 | 110.69M shares derived: average of 4 quarters · filed 2022-05-11 | ||||
| 2021-06-30 | 152.46M shares 10-Q · filed 2021-08-12 | 114.93M shares 10-Q · filed 2021-08-12 | 96.72M shares derived: average of 3 quarters · filed 2022-05-11 | 87.61M shares derived: average of 4 quarters · filed 2022-05-11 | ||||
| 2021-03-31 | 76.99M shares 10-Q · filed 2022-05-11 | 68.85M shares derived: average of 2 quarters · filed 2022-05-11 | 66.00M shares derived: average of 3 quarters · filed 2022-05-11 | 64.21M shares derived: average of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | 60.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 60.50M shares derived: average of 2 quarters · filed 2022-03-30 | 59.95M shares derived: average of 3 quarters · filed 2022-03-30 | 59.31M shares 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | 60.29M shares 10-Q · filed 2021-11-12 | 59.57M shares derived: average of 2 quarters · filed 2021-11-12 | 58.84M shares 10-Q · filed 2021-11-12 | 55.09M shares derived: average of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | 58.86M shares 10-Q · filed 2021-08-12 | 58.11M shares 10-Q · filed 2021-08-12 | 53.36M shares derived: average of 3 quarters · filed 2021-08-12 | 50.45M shares derived: average of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | 57.36M shares 10-Q · filed 2021-05-13 | 50.61M shares derived: average of 2 quarters · filed 2021-05-13 | 47.65M shares derived: average of 3 quarters · filed 2021-05-13 | 45.35M shares derived: average of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | 43.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | 42.80M shares derived: average of 2 quarters · filed 2021-03-10 | 41.34M shares derived: average of 3 quarters · filed 2021-03-10 | 40.03M shares 10-K · filed 2021-03-10 | ||||
| 2019-09-30 | 41.73M shares 10-Q · filed 2020-11-05 | 40.08M shares derived: average of 2 quarters · filed 2020-11-05 | 38.75M shares 10-Q · filed 2020-11-05 | 38.03M shares derived: average of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | 38.44M shares 10-Q · filed 2020-08-06 | 37.24M shares 10-Q · filed 2020-08-06 | 36.80M shares derived: average of 3 quarters · filed 2020-08-06 | 36.22M shares derived: average of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | 36.02M shares 10-Q · filed 2020-05-07 | 35.97M shares derived: average of 2 quarters · filed 2020-05-07 | 35.48M shares derived: average of 3 quarters · filed 2020-05-07 | 34.47M shares derived: average of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | 35.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 35.21M shares derived: average of 2 quarters · filed 2020-03-12 | 33.95M shares derived: average of 3 quarters · filed 2020-03-12 | 33.30M shares 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | 34.48M shares 10-Q · filed 2019-11-07 | 33.71M shares 10-Q · filed 2018-11-07 | 32.96M shares derived: average of 2 quarters · filed 2019-11-07 | 32.42M shares 10-Q · filed 2019-11-07 | 31.65M shares 10-Q · filed 2018-11-07 | 31.50M shares derived: average of 4 quarters · filed 2019-11-07 | ||
| 2018-06-30 | 31.43M shares 10-Q · filed 2019-08-08 | 30.66M shares 10-Q · filed 2018-08-09 | 31.38M shares 10-Q · filed 2019-08-08 | 30.60M shares 10-Q · filed 2018-08-09 | 30.51M shares derived: average of 3 quarters · filed 2019-08-08 | 28.93M shares derived: average of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | 31.32M shares 10-Q · filed 2019-05-09 | 30.54M shares 10-Q · filed 2018-05-09 | 30.05M shares derived: average of 2 quarters · filed 2019-05-09 | 28.10M shares derived: average of 3 quarters · filed 2019-05-09 | 24.53M shares derived: average of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | 28.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | 26.49M shares derived: average of 2 quarters · filed 2019-03-13 | 22.26M shares derived: average of 3 quarters · filed 2019-03-13 | 17.52M shares 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | 24.21M shares 10-Q · filed 2018-11-07 | 19.01M shares derived: average of 2 quarters · filed 2018-11-07 | 13.77M shares 10-Q · filed 2018-11-07 | 71.29M shares derived: average of 4 quarters · filed 2018-11-07 | ||||
| 2017-06-30 | 13.81M shares 10-Q · filed 2018-08-09 | 8.47M shares 10-Q · filed 2018-08-09 | 86.98M shares derived: average of 3 quarters · filed 2018-08-09 | 65.91M shares derived: average of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | 3.03M shares 10-Q · filed 2018-05-09 | 3.64M shares 10-Q · filed 2017-05-09 | 123.56M shares derived: average of 2 quarters · filed 2018-05-09 | 83.28M shares derived: average of 3 quarters · filed 2018-05-09 | 62.72M shares derived: average of 4 quarters · filed 2018-05-09 | |||
| 2016-12-31 | 244.09M shares 10-K · filed 2017-03-06 | 123.40M shares derived: average of 2 quarters · filed 2017-11-08 | 82.62M shares derived: average of 3 quarters · filed 2017-11-08 | 1.96M shares 10-K · filed 2018-03-14 | 208.48M shares 10-K · filed 2017-03-06 | |||
| 2016-09-30 | 2.71M shares 10-Q · filed 2017-11-08 | 214.71M shares 10-Q · filed 2016-11-08 | 1.88M shares derived: average of 2 quarters · filed 2017-11-08 | 1.60M shares 10-Q · filed 2017-11-08 | 196.53M shares 10-Q · filed 2016-11-08 | 42.48M shares derived: average of 4 quarters · filed 2017-11-08 | ||
| 2016-06-30 | 1.04M shares 10-Q · filed 2017-08-09 | 196.55M shares 10-Q · filed 2016-08-09 | 1.03M shares 10-Q · filed 2017-08-09 | 187.33M shares 10-Q · filed 2016-08-09 | 55.73M shares derived: average of 3 quarters · filed 2017-08-09 | 82.70M shares derived: average of 4 quarters · filed 2017-08-09 | ||
| 2016-03-31 | 2.54M shares 10-Q · filed 2017-05-09 | 178.12M shares 10-Q · filed 2016-05-06 | 83.08M shares derived: average of 2 quarters · filed 2017-05-09 | 109.92M shares derived: average of 3 quarters · filed 2017-05-09 | 122.98M shares derived: average of 4 quarters · filed 2017-05-09 | |||
| 2015-12-31 | 163.61M shares 10-K · filed 2017-03-06 | 163.61M shares derived: average of 2 quarters · filed 2017-03-06 | 163.12M shares derived: average of 3 quarters · filed 2017-03-06 | 968.81K shares 10-K · filed 2018-03-14 | 162.22M shares 10-K · filed 2016-03-14 | |||
| 2015-09-30 | 163.61M shares 10-K · filed 2017-03-06 | 163.61M shares 10-Q · filed 2015-11-12 | 162.87M shares derived: average of 2 quarters · filed 2017-03-06 | 161.75M shares 10-Q · filed 2016-11-08 | 157.61M shares derived: average of 4 quarters · filed 2017-03-06 | |||
| 2015-06-30 | 162.13M shares 10-K · filed 2017-03-06 | 162.13M shares 10-Q · filed 2015-08-12 | 160.80M shares 10-Q · filed 2016-08-09 | 155.61M shares derived: average of 3 quarters · filed 2017-03-06 | 147.53M shares derived: average of 4 quarters · filed 2017-03-06 | |||
| 2015-03-31 | 159.46M shares 10-K · filed 2017-03-06 | 159.46M shares 10-Q · filed 2015-05-11 | 152.36M shares derived: average of 2 quarters · filed 2017-03-06 | 142.67M shares derived: average of 3 quarters · filed 2017-03-06 | 135.90M shares derived: average of 4 quarters · filed 2017-03-06 | |||
| 2014-12-31 | 145.26M shares 10-K · filed 2017-03-06 | 134.27M shares derived: average of 2 quarters · filed 2017-03-06 | 128.04M shares derived: average of 3 quarters · filed 2017-03-06 | 122.41M shares 10-K · filed 2017-03-06 | ||||
| 2014-09-30 | 123.29M shares 10-K · filed 2017-03-06 | 123.29M shares 10-Q · filed 2014-10-31 | 119.44M shares derived: average of 2 quarters · filed 2017-03-06 | 114.71M shares 10-Q · filed 2015-11-12 | 111.66M shares derived: average of 4 quarters · filed 2017-03-06 | |||
| 2014-06-30 | 115.59M shares 10-K · filed 2017-03-06 | 115.59M shares 10-Q · filed 2014-08-11 | 110.35M shares 10-Q · filed 2015-08-12 | 107.78M shares derived: average of 3 quarters · filed 2017-03-06 | 106.52M shares derived: average of 4 quarters · filed 2017-03-06 | |||
| 2014-03-31 | 105.05M shares 10-K · filed 2017-03-06 | 105.05M shares 10-Q · filed 2014-05-05 | 103.88M shares derived: average of 2 quarters · filed 2017-03-06 | 103.49M shares derived: average of 3 quarters · filed 2017-03-06 | 91.06M shares derived: average of 4 quarters · filed 2017-03-06 | |||
| 2013-12-31 | 102.71M shares 10-K · filed 2015-03-24 | 102.71M shares 10-K · filed 2014-03-26 | 102.71M shares derived: average of 2 quarters · filed 2015-03-24 | 86.39M shares derived: average of 3 quarters · filed 2015-03-24 | 76.59M shares 10-K · filed 2015-03-24 | |||
| 2013-09-30 | 102.71M shares 10-K · filed 2015-03-24 | 102.71M shares 10-Q · filed 2013-11-04 | 78.23M shares derived: average of 2 quarters · filed 2015-03-24 | 67.78M shares 10-Q · filed 2014-10-31 | 62.54M shares derived: average of 4 quarters · filed 2015-03-24 | |||
| 2013-06-30 | 53.75M shares 10-K · filed 2015-03-24 | 53.75M shares 10-Q · filed 2013-08-05 | 50.03M shares 10-Q · filed 2014-08-11 | 49.14M shares derived: average of 3 quarters · filed 2015-03-24 | 48.79M shares derived: average of 4 quarters · filed 2015-03-24 | |||
| 2013-03-31 | 46.27M shares 10-K · filed 2015-03-24 | 46.27M shares 10-Q · filed 2013-05-15 | 46.84M shares derived: average of 2 quarters · filed 2015-03-24 | 47.13M shares derived: average of 3 quarters · filed 2015-03-24 | 47.28M shares derived: average of 4 quarters · filed 2015-03-24 | |||
| 2012-12-31 | 47.42M shares 10-K · filed 2014-03-26 | 47.72M shares 10-K · filed 2013-03-19 | 47.57M shares derived: average of 2 quarters · filed 2014-03-26 | 47.62M shares derived: average of 3 quarters · filed 2014-03-26 | 47.64M shares 10-K · filed 2014-03-26 | |||
| 2012-09-30 | 47.72M shares 10-K · filed 2014-03-26 | 47.72M shares derived: average of 2 quarters · filed 2014-03-26 | 47.72M shares 10-Q · filed 2013-11-04 | 45.06M shares derived: average of 4 quarters · filed 2014-03-26 | ||||
| 2012-06-30 | 47.72M shares 10-K · filed 2014-03-26 | 47.72M shares 10-Q · filed 2013-08-05 | 44.17M shares derived: average of 3 quarters · filed 2014-03-26 | 39.75M shares derived: average of 4 quarters · filed 2014-03-26 | ||||
| 2012-03-31 | 47.72M shares 10-K · filed 2014-03-26 | 42.40M shares derived: average of 2 quarters · filed 2014-03-26 | 37.09M shares derived: average of 3 quarters · filed 2014-03-26 | 34.38M shares derived: average of 4 quarters · filed 2014-03-26 | ||||
| 2011-12-31 | 37.09M shares 10-K · filed 2013-03-19 | 31.78M shares derived: average of 2 quarters · filed 2013-03-19 | 29.94M shares derived: average of 3 quarters · filed 2013-03-19 | 28.14M shares derived: average of 4 quarters · filed 2013-03-19 | ||||
| 2011-09-30 | 26.47M shares 10-K · filed 2013-03-19 | 26.36M shares derived: average of 2 quarters · filed 2013-03-19 | 25.16M shares derived: average of 3 quarters · filed 2013-03-19 | |||||
| 2011-06-30 | 26.25M shares 10-K · filed 2013-03-19 | 24.50M shares derived: average of 2 quarters · filed 2013-03-19 | ||||||
| 2011-03-31 | 22.76M shares 10-K · filed 2013-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |